Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 19;63(2):e0151524.
doi: 10.1128/jcm.01515-24. Epub 2025 Jan 6.

Rapidly spreading Enterobacterales with OXA-48-like carbapenemases

Affiliations
Review

Rapidly spreading Enterobacterales with OXA-48-like carbapenemases

Gisele Peirano et al. J Clin Microbiol. .

Abstract

Enterobacterales (mostly Klebsiella pneumoniae, Escherichia coli) with OXA-48-like carbapenemases (e.g., OXA-48, -181, -232, -244) are undermining the global efficiency of carbapenem therapy. In the Middle East, North Africa, and some European countries, OXA-48-like carbapenemases are the most common types of carbapenemases among Enterobacterales. Currently, OXA-48 is endemic in the Middle East, North Africa, Spain, France, and Belgium; OXA-181 is endemic in Sub-Saharan Africa and the Indian Subcontinent, while OXA-232 has been increasing in the Indian Subcontinent. European countries (e.g., Germany, Denmark, Switzerland, France) are experiencing community outbreaks with E. coli ST38 that produce OXA-244, and these strains have been introduced into Norwegian, Polish, and Czech hospitals. The global ascendancy of OXA-48-like genes is due to the combination of carbapenemases with horizontal spread through promiscuous plasmids (e.g., IncL, IncX3, ColE2) and vertical spread with certain high-risk multidrug-resistant clones (e.g., K. pneumoniae ST14, ST15, ST147, ST307; E. coli ST38, ST410). This is a powerful "gene survival strategy" that has assisted with the survival of OXA-48-like genes in different environments including the community setting. The laboratory diagnosis is complex; therefore, bacteria with "difficult to detect" variants (e.g., OXA-244, OXA-484) are likely underreported and are spreading silently "beneath the radar" in hospital and community settings. K. pneumoniae and E. coli with OXA-48-like carbapenemases are forces to be reckoned with.

Keywords: OXA-48-like; carbapenemases; epidemiology; laboratory detection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
(A) The origin and evolution of cluster A_OXA-48 (OXA-48 and OXA-244). (B) The origin and evolution of cluster B_OXA-181 (OXA-181 and OXA-232).
Fig 2
Fig 2
(Bottom) The global (excluding Europe) distribution of Enterobacterales with OXA-48, OXA-181, OXA-232, and OXA-244. (Inset, top) The European distribution of Enterobacterales with OXA-48, OXA-181, OXA-232, and OXA-244.

Similar articles

Cited by

References

    1. Pitout JD, Peirano G, DeVinney R. 2023. The contributions of multidrug resistant clones to the success of pandemic extra-intestinal Pathogenic Escherichia coli. Expert Rev Anti Infect Ther 21:343–353. doi:10.1080/14787210.2023.2184348 - DOI - PubMed
    1. Pitout JDD, Chen L. 2023. The significance of epidemic plasmids in the success of multidrug-resistant drug pandemic extraintestinal pathogenic Escherichia coli. Infect Dis Ther 12:1029–1041. doi:10.1007/s40121-023-00791-4 - DOI - PMC - PubMed
    1. Pitout JDD, Nordmann P, Poirel L. 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873–5884. doi:10.1128/AAC.01019-15 - DOI - PMC - PubMed
    1. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother 54:24–38. doi:10.1128/AAC.01512-08 - DOI - PMC - PubMed
    1. Kidd JM, Livermore DM, Nicolau DP. 2020. The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases. Clin Microbiol Infect 26:401–403. doi:10.1016/j.cmi.2019.12.006 - DOI - PubMed

MeSH terms

LinkOut - more resources